Doral and Dyspnea exacerbated - a phase IV clinical study of FDA data

Summary:

Dyspnea exacerbated is reported as a side effect among people who take Doral (quazepam), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Allopurinol, and have Insomnia.

The phase IV clinical study analyzes which people have Dyspnea exacerbated when taking Doral. It is created by eHealthMe based on reports of 1,036 people who have side effects when taking Doral from the FDA, and is updated regularly.

What is Doral?

Doral has active ingredients of quazepam. eHealthMe is studying from 1,039 Doral users. Check the latest studies of Doral.

What is Dyspnea exacerbated?

Dyspnea exacerbated is found to be associated with 3,301 drugs and 1,658 conditions by eHealthMe. Check the latest studies of Dyspnea exacerbated.

On Jul, 10, 2026

1,036 people reported to have side effects when taking Doral.
Among them, 18 people (1.74%) have Dyspnea exacerbated.

Among these 18 people:

How long have people been on Doral when they have Dyspnea exacerbated? *

What is the gender of people who have Dyspnea exacerbated when taking Doral? *

female: 72.22 %
male: 27.78 %

What is the age of people who have Dyspnea exacerbated when taking Doral? *

What are other drugs people take besides Doral? *

What are other side effects people have besides Dyspnea exacerbated? *

Fever: 8 people, 44.44%
Loss Of Consciousness: 5 people, 27.78%
Confusion: 4 people, 22.22%
Breathing Sounds - Abnormal (Stridor): 4 people, 22.22%
Dizziness: 3 people, 16.67%
High Blood Pressure: 3 people, 16.67%
Rashes (redness): 3 people, 16.67%
Sputum Retention: 3 people, 16.67%
Inflammation: 3 people, 16.67%
Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 3 people, 16.67%

What are the existing conditions these people have? *

Insomnia (sleeplessness): 5 people, 27.78%
Premenstrual Syndrome: 2 people, 11.11%
Dysmenorrhea (painful menstruation): 2 people, 11.11%
Stress And Anxiety: 1 person, 5.56%
Dementia (madness): 1 person, 5.56%
Depression: 1 person, 5.56%
Extrapyramidal Disorder (involuntary muscle spasms in the face and neck): 1 person, 5.56%
Gout (uric acid crystals building up in the body): 1 person, 5.56%
Indigestion: 1 person, 5.56%
Muscle Aches (muscle pain): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Doral and have Dyspnea exacerbated?

- Check whether Dyspnea exacerbated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Doral:

Doral (1,039 reports)

Browse all side effects of Doral:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dyspnea exacerbated:

Dyspnea exacerbated (3,301 drugs)

Browse all the conditions that are associated with Dyspnea exacerbated:

Dyspnea exacerbated (1,658 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on quazepam (the active ingredients of Doral) and Doral (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.